Foreign exchangemixed · 2 filings
“The currency impact to net sales measures the change in net sales between current and prior year periods using constant exchange rates.”10-Q · Sep 8, 2026 ↗
MiniMed Group, Inc.
MMED
Market read
MiniMed Group, Inc.'s current read is isolated; its market group is not confirming.
No new filing conclusion is available. 0 of 1 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 8 directly disclosed connections are confirming.
Revenue YoY+14.3%2026-04-24
Operating margin-6.1%-0.7 pts YoY
Company-1.4% todayVolume comparison unavailable
Market group0 of 1 activeDiabetes Devices · unavailable
Disclosed network0 of 8 confirmingNo filing-linked name is confirming now
What would change this read
Watch this read- Sales growth was attributed to higher volumes in both international and U.S. markets, with an additional week also affecting the comparison.
Invalidation: The isolated read changes if MMED's group or a disclosed connection begins moving with it.
Research brief
The story so far
No new filing conclusion is available. 0 of 1 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 8 directly disclosed connections are confirming.
Evidence that supports
No thresholded supportive filing evidence is available yet.
Evidence that challenges
No thresholded adverse filing evidence is available yet.
What would clarify the read
- Sales growth was attributed to higher volumes in both international and U.S. markets, with an additional week also affecting the comparison.
Company research
Understand the business, not just the ticker
Business model and earnings drivers
Use the company’s filings to identify the few operating, demand, cost, capital and regulatory variables that determine its earnings power.
Key research questions
- Which operating variable is changing?
- Is that change durable, cyclical or one-off?
- What evidence would disprove the current interpretation?
Annual periods3
Price observations130
Usable filing statements46
Verified relationships11
Evidence supporting the case
- Latest annual revenue changed +14.3% year over year.
Evidence challenging the case
- Net margin changed -2.9 percentage points in the latest annual period.
Questions before a position
No credible peer-relative valuation comparison is available yet.
Longer-term price context
Price as of Sep 9, 2026
22.766m+24.2%12m—24m—
Annual trajectory
Reported annual revenue and per-share history. This is accounting history, not a forecast.
PeriodRevenueYoYDiluted EPSShare change
2024-04-26$2.5B—$-0.44—
2025-04-25$2.7B+10.0%$-0.84+0.0%
2026-04-24$3.1B+14.3%$-1.30+1.5%
What management says matters
Persistent and emerging business drivers
Legal and regulatory exposuremixed · 2 filings
“15 Diabetes Pump Retainer Ring Litigation Starting in fiscal year 2021, plaintiffs began filing lawsuits against the Company in U.S.”10-Q · Sep 8, 2026 ↗
Restructuring and cost reductionsnegative · 2 filings
“The Company’s effective tax rate for the three months ended July 25, 2025 was lower than the U.S.”10-Q · Sep 8, 2026 ↗
Credit and interest ratesmixed · 1 filings
“Third-party debt and related interest expense of Medtronic were not attributed to the Company for the periods presented as the Company was not the sole legal obligor of such debt and Medtronic’s borrowings were not directly attributable to the Company, nor se…”10-K · Jun 29, 2026 ↗
Valuation discipline
Descriptive valuation snapshot
Price/sales 1.9× · EV/sales 1.8×. Comparisons use only industry-matched filing peers.
Scenario scaffold
Fewer than 4 annual revenue periods; too little history to scaffold scenarios.
Price action
How the market is pricing the story
22.44-1.4% today
Jodie does not have enough daily observations to draw a useful short-term chart for this asset. The latest quoted price was checked 10 Sept, 15:55 GMT-4; this is a coverage limitation, not a flat-price conclusion.
Developments
No sourced recent-development timeline yet
Jodie has not returned a relevant primary source or news item for MMED. This is an evidence-coverage gap, not a conclusion that nothing material happened.
Business and financial condition
Reported financial figures are not available yet
Jodie has not returned structured SEC XBRL fundamentals for this asset. This is a coverage limitation, not an assessment of the business or its financial health.
Filing analysis
No comparable filing assessment is available yet
Jodie has not yet found a suitable current-versus-prior filing comparison for MMED. This does not mean the latest filing was neutral or immaterial.
Business ecosystem
The relationships behind MMED
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depends on
MDTMedtronic plcinvesteeJun 29, 2026 ▾
“Historically, MiniMed operated as Medtronic plc’s (“Medtronic”) global diabetes business (the “Diabetes Business”).”
ABTAbbott LaboratoriespartnerJun 29, 2026 ▾
“On June 3, 2026, we announced an extension to our partnership with Abbott Laboratories, to commercialize dual glucose-ketone sensors designed to integrate exclusively with our MiniMed smart dosing systems.”
Depended on by
MDTMedtronic plcpartnerNov 25, 2025 ▾
“The increase in net sales was primarily driven by strong international growth due to the continued adoption of the MiniMed 780G AID system, including the Simplera Sync and Guardian 4 CGM sensors and Extended Infusion Sets, and the impacts of foreign currency…”
Filing peers
Companies whose filings use similar operating language.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks 5 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
MMED is currently a Leader in the organic co-movement group Diabetes Devices. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.
This group is retained as the last observed read for MMED; it is not active in the latest market snapshot.
Context history
Theme membership history
No durable theme membership has been observed for this name yet.